1.Fawcett, J, Kravitz, HM. Treatment refractory depression. In: Schatzberg AF, editor. Common treatment problems in depression. Washington, DC: American Psychiatric Press, 1985, 1–27.
2.Schosser, A, Serretti, A, Souery, Det al. European Group for the Study of Resistant Depression (GSRD) – where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmcol 2012a; 22:453–468.
3.Konstantinidis, A, Papageorgiou, K, Grohmann, Ret al. Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: Results from the AMSP International Pharmacovigilance Program. Int J Neuropsychopharmacol 2012;15:449–457.
4.Souery, D, Oswald, P, Massat, Iet al. Clinical factors associated with treatment resistance in major depression: results from a European multicenter study. J Clin Psychiatry 2007;68:1062–1070.
5.Mendlewicz, J, Massat, I, Linotte, Set al. Identification of clinical factors associated with resistance to antidepressants in bipolar depression. Results from a European multicentre study. Int Clin Psychopharmacol 2010;25:297–301.
6.Souery, D, Serretti, A, Calati, Aet al. Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. World J Biol Psychiatry 2011;12:364–375.
7.Papakostas, GI, Fava, M, Thase, ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry 2008;63:699–704.
8.Kasper, S, Montgomery, S. Treatment-resistant depression. Chichester: Wiley-Blackwell, 2013.
9.Serretti, A, Calati, R, Massat, Iet al. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. Int Clin Psychopharmacol 2009;24:250–256.
10.Kocabas, NA, Faghel, C, Barreto, Met al. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Int Clin Psychopharmacol 2010;25:218–227.
11.Massat, I, Kocabas, NA, Crisafulli, Cet al. COMT and age at onset in mood disorders: a replication and extension study. Neurosci Lett 2011;498:218–221.
12.Schosser, A, Calati, R, Serretti, Aet al. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder – A European multicenter study. Eur Neuropsychopharmacol 2012b;22:259–266.
13.Schosser, A, Kasper, S. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol 2009;24:277–288.
14.Serretti, A, Fabbri, C. Shared genetics among major psychiatric disorders. Lancet 2013;381:1339–1341.